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Supplementary	Figure	1	Schematic	overview	of	this	study.		
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Supplementary	 Figure	 2	 Estimated	 rb	 between	 two	 tissues	 at	 different	 levels	 of	 residual	correlation	 (re)	 in	 simulations.	The	phenotypes	were	simulated	based	on	 the	UK10K	data	set1	with	the	SNPs	in	common	with	HapMap3	(see	Supplementary	Note	1	for	details).	In	brief,	we	simulated	gene	expression	data	in	three	tissues	with	correlated	eQTL	effects	and	residuals.	In	the	
rb	 analysis	of	 the	 simulated	data,	 to	avoid	bias	due	 to	 the	winner’s	 curse,	we	selected	 the	 top	associated	SNPs	at	PeQTL	<	5´10-8	in	tissue	#1,	and	estimated	the	correlation	of	top	cis-eQTL	effects	between	tissues	#2	and	#3.	Each	box	in	the	figure	represents	the	distribution	of	estimates	from	100	simulation	replicates.	The	red	dash	line	represents	the	simulation	parameter	(i.e.	𝜌	=	0.7).		It	is	of	note	that	here	we	compare	the	estimate	of	rb	between	tissues	#2	and	#3	for	genes	with	cis-eQTLs	of	relatively	large	effect	(because	of	the	ascertainment	of	the	top	cis-eQTLs	by	a	stringent	p-value	threshold	in	tissue	#1)	with	the	parameter	(𝜌)	used	to	simulate	the	correlation	of	cis-eQTLs	 effects	 between	 the	 tissues	 across	 all	 genes	 (Supplementary	 Note	 1).	 Therefore,	 the	estimate	of	rb	is	not	expected	to	be	an	unbiased	estimator	of	𝜌.	
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Supplementary	Figure	3	Schematic	overview	of	the	rb	analysis.	
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Supplementary	Figure	4	Distributions of the LD correlations among 4,257 top cis-eQTLs and the 
estimated Jackknife sample variation from 100 simulation replicates. The 4,257 genes were selected at 
PeQTL	<	5´10-8	in	GTEx-muscle.	Shown	in	panel	a	is	the	distribution	of	the	LD	correlations	among	4,257	top	cis-eQTLs	computed	from	the	GTEx	genotype	data.	The	4,257	cis-eQTLs	are	distributed	across	the	whole	genome	with	a	mean	LD	r	=	0.0008	(SD	=	0.0575),	suggesting	that	most	of	them	are	 independent.	 Shown	 in	panel	b	 is	 the	distribution	of	 estimated	 Jackknife	 sample	variance	across	100	simulation	replicates.	We	simulated	gene	expression	data	based	on	the	UK10K	data	set1	with	the	SNPs	in	common	with	HapMap3	(see	Supplementary	Note	1	for	details)	in	three	tissues	with	correlated	eQTL	effects	(rb	=	0.7)	and	residuals	(re	=	-0.7).	In	the	rb	analysis	of	the	simulated	data,	to	avoid	bias	due	to	the	winner’s	curse,	we	selected	the	top	associated	SNPs	at	
PeQTL	<	5´10-8	in	tissue	#1,	and	estimated	the	correlation	of	top	cis-eQTL	effects	between	tissues	#2	 and	 #3.	 The	 dots	 in	 panel	 b	 represent	 estimated	 Jackknife	 sample	 variance	 from	 100	simulation	 replicates.	 The	 red	 dash	 line	 represents	 the	 variance	 of	 estimated	 rb	 from	100	simulation	replicates.	It	is	of	note	that	the	mean	Jackknife	sample	variance	is	slightly	larger	than	the	observed	sample	variance.		
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Supplementary	Figure	5	Estimated	rb	of	cis-eQTLs	among	10	brain	regions	in	Braineac.	The	top	cis-eQTLs	were	selected	from	GTEx-muscle	at	PeQTL	<	5´10-8.	We	matched	the	Braineac	data	with	GTEx-muscle	by	gene	symbols	and	excluded	genes	tagged	by	multiple	probes.	Shown	in	each	cell	is	the	estimate	of	rb	with	its	standard	error	given	in	the	parentheses	(Methods).	FCTX,	frontal	cortex;	HIPP,	hippocampus;	MEDU,	medulla	(specifically	inferior	olivary	nucleus);	OCTX,	occipital	cortex	 (specifically	 primary	 visual	 cortex);	 PUTM,	 putamen;	 SNIG,	 substantia	 nigra;	 THAL,	thalamus;	TCTX,	temporal	cortex;	WHMT,	intralobular	white	matter;	CRBL,	cerebellar	cortex.		
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Supplementary	 Figure	 6	 Estimated	 rb	 of	 the	 scaled	 cis-eQTL	 effects	 between	 brain	 regions,	between	brain	and	blood	tissues,	and	between	data	sets.	We	know	that	the	SE	of	an	estimated	eQTL	 effect	 is	 a	 function	 of	 the	 minor	 allele	 frequency	 (MAF)	 of	 the	 eQTL.	 In	 the	 analysis	presented	in	Figure	1,	we	used	the	mean	SE	squared	across	genes	to	estimate	the	variance	of	estimation	 errors	 (Methods).	 However,	 MAFs	 of	 cis-eQTLs	 are	 different	 across	 genes.	 We	therefore	scaled	the	eQTL	effect	size	and	SE	as	𝑏#$%&' = 𝑏 2𝑝(1 − 𝑝)		and	𝑠#$%&' = 𝑠 2𝑝(1 − 𝑝),	where	𝑏#$%&' 	is	interpreted	as	the	eQTL	effect	size	per-standardized	genotype,	𝑝	is	MAF,	𝑏	is	the	estimated	eQTL	effect,	and	𝑠	is	the	standard	error	of	𝑏.	We	then	re-ran	the	rb	analysis	using	the	scaled	 cis-eQTL	 effects	 and	 SEs	 (Methods).	 The	 top	 cis-eQTLs	were	 selected	 from	 the	 GTEx-muscle	data	at	PeQTL	<	5´10-8.	Shown	in	each	cell	is	the	estimate	of	rb	with	its	standard	error	given	in	the	parentheses.	These	results	are	almost	identical	to	those	presented	in	Figure	1,	suggesting	that	the	method	is	robust	to	scale	transformation	of	the	eQTL	effects.	
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Supplementary	Figure	7	Estimated	rb	of	cis-eQTLs	between	brain	regions,	between	brain	and	blood	tissues,	and	between	data	sets,	excluding	the	cis-QTLs	within	10Kb	of	the	promoter	regions.	Shown	in	each	cell	is	the	estimate	of	rb	with	its	standard	error	given	in	the	parentheses	(Methods).
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Supplementary	Figure	8	Estimated	rb	of	cis-eQTLs	between	brain	regions,	between	brain	and	blood	tissues,	and	between	data	sets,	excluding	the	housekeeping	(HK)	genes	obtained	from	Lin	et	al.2	(upper	right)	and	Eisenberg	et	al.3	(lower	left).	There	were	4,257	genes	in	our	ascertained	gene	 list.	 The	 number	 of	HK	 genes	 in	 the	 ascertained	 gene	 list	 (e.g.	m	 =	 220	 for	 Lin	 et	 al.)	 is	significantly	higher	than	what	we	would	expect	from	a	random	sample	of	genes	(mean	=	187	with	SD	=	12.2	from	2,000	random	gene	sets).	This	is	expected,	because	HK	genes	are	defined	as	a	set	of	genes	expressed	across	most	cell	types	and	tissues,	which	are	expected	to	be	enriched	in	genes	expressed	in	both	brain	and	blood.	We	re-ran	the	rb	analysis	excluding	the	HK	genes.	The	results	are	almost	identical	to	those	presented	in	Figure	1,	suggesting	that	the	estimates	of	rb	are	robust	to	the	inclusion/exclusion	of	HK	genes.	Shown	in	each	cell	is	the	estimate	of	rb	with	its	standard	error	given	in	the	parentheses	(Methods).	
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Supplementary	Figure	9	Estimated	rb	of	cis-eQTLs	including	both	the	primary	and	secondary	signals	 between	 brain	 regions,	 between	 brain	 and	 blood	 tissues,	 and	 between	 data	 sets.	Conditional	 analysis	 was	 performed	 in	 each	 of	 the	 cis-eQTL	 regions	 in	 GTEx-muscle	 using	 a	summary-data-based	conditional	analysis	method	in	GCTA4,5.	We	identified	secondary	signals	by	the	conditional	analysis	for	659	probes.	Shown	in	each	cell	is	the	estimate	of	rb	with	its	standard	error	given	in	the	parentheses	(Methods).	
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Supplementary	Figure	10	 Estimated	 rb	 of	 cis-eQTLs	between	 two	versions	 of	 CMC	data	 and	GTEx-brain,	 GTEx-blood	 and	 ROSMAP.	 CMC_SVA	 represents	 gene	 expression	 data	 in	 CMC	adjusted	by	the	surrogate	variable	analysis	(SVA),	where	SVA	is	an	approach	used	to	overcome	the	problems	caused	by	heterogeneity	in	expression	studies6.	CMC_NoVSA	represents	CMC	data	without	SVA	adjustment.	Shown	in	each	cell	is	the	estimate	of	rb	with	its	standard	error	given	in	the	parentheses	(Methods).																					
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Supplementary	Figure	11	Estimated	rb	among	11	GTEx	tissues	for	cis-eQTL	ascertained	from	CMC.	The	top	cis-eQTLs	were	selected	from	the	CMC	data	at	PeQTL	<	5´10-8.	Shown	in	each	cell	is	the	estimate	of	rb	with	its	standard	error	given	in	the	parentheses	(Methods).			
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Supplementary	 Figure	 12	 Proportion	 of	 eQTLs	 with	 significant	 difference	 in	 effect	 size	between-tissues	(after	Bonferroni	correction	for	multiple	testing)	as	a	function	of	sample	size	and	
rb.	 Each	dot	 represents	 the	mean	 estimate	 from	1,000	 simulation	 replicates	 (Supplementary	
Note	1).			
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	Supplementary	 Figure	13	Enrichment	 of	 cis-eQTLs	with	 tissue-specific	 effects	 in	 functional	annotations.	 a	 The	 distribution	 of	 cis-eQTLs	 across	 14	 functional	 categories	 derived	 from	Roadmap	Epigenomics	Mapping	Consortium	(REMC)	(Methods).	b	Estimated	enrichment	of	test-statistics	 for	 the	 difference	 (TD)	 (testing	 for	 the	 difference	 in	 cis-eQTL	 effect	 between	 GTEx-cerebellum	and	GTEx-blood)	in	each	functional	category	(Methods).	Error	bars	represent	95%	confidence	intervals	around	the	estimates.		The	black	dash	line	represents	fold	enrichment	of	1.	Different	colors	in	panels	a	and	b	represent	the	14	functional	categories	from	REMC:	TssA,	active	transcription	 start	 site;	 Prom,	 upstream/downstream	 TSS	 promoter;	 Tx,	 actively	 transcribed	state;	 TxWk,	 weak	 transcription;	 TxEn,	 transcribed	 and	 regulatory	 Prom/Enh;	 EnhA,	 active	enhancer;	EnhW,	weak	enhancer;	DNase,	primary	DNase;	ZNF/Rpts,	state	associated	with	zinc	finger	 protein	 genes;	 Het,	 constitutive	 heterochromatin;	 PromP,	 Poised	 promoter;	 PromBiv,	bivalent	regulatory	states;	ReprPC,	repressed	Polycomb	states;	and	Quies,	a	quiescent	state.			
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Supplementary	Figure	14	Shown	is	an	example	where	a	top	cis-eQTL	with	tissue-specific	effect	is	located	in	an	enhancer	region.	The	top	eQTL	was	selected	from	GTEx-muscle	at	PeQTL	<	5´10-8.	Showing	in	the	top	four	plots	are	–log10(P	values)	for	eQTLs	of	all	the	cis-SNPs	for	gene	CCDC163P	in	 GTEx-muscle,	 CMC,	 GTEx-cerebellum,	 and	 GTEx-blood	 respectively.	 Each	 row	 represents	 a	REMC	sample.	The	blue	asterisk	in	the	top	plot	indicates	the	top	eQTL	which	co-localizes	a	tissue-specific	 enhancer	 region	 in	 brain.	 The	 bottom	 plot	 shows	 14	 chromatin	 state	 annotations	(indicated	by	different	colours)	of	the	region	derived	from	the	Roadmap	Epigenomics	Mapping	Consortium	 (REMC)	 (Methods).	 TssA,	 active	 transcription	 start	 site;	 Prom,	upstream/downstream	TSS	promoter;	Tx,	actively	transcribed	state;	TxWk,	weak	transcription;	TxEn,	 transcribed	 and	 regulatory	 Prom/Enh;	 EnhA,	 active	 enhancer;	 EnhW,	 weak	 enhancer;	DNase,	 primary	 DNase;	 ZNF/Rpts,	 state	 associated	 with	 zinc	 finger	 protein	 genes;	 Het,	constitutive	 heterochromatin;	 PromP,	 Poised	 promoter;	 PromBiv,	 bivalent	 regulatory	 states;	ReprPC,	repressed	Polycomb	states;	and	Quies,	a	quiescent	state.	
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Supplementary	 Figure	 15	 Estimated	 rb	 of	 cis-mQTLs	 between	 brain	 and	 blood	 in	 different	samples.	The	top	cis-mQTLs	were	ascertained	in	LBC	at	PmQTL	<	5´10-8.	In	the	ROSMAP	data,	only	SNPs	within	5Kb	of	the	DNAm	probes	were	available	which	might	result	in	a	downward	bias	of	the	rb	estimate.	
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Supplementary	Figure	16	MeCS	results	from	simulations	under	the	null	hypothesis	that	there	is	no	cis-eQTL	effect.	MeCS-PheCor	represents	a	MeCS	analysis	where	correlation	of	estimation	error	(𝜃)	is	estimated	by	phenotypic	correlation	from	individual-level	data.	a	Quantile-quantile	plot	for	MeCS	under	the	null	model.	b	Estimated	𝜃	from	summary	data	vs.	that	from	individual-level	data	(sample	overlap	=	1).	c	Estimated	effect	size	from	MeCS	vs.	that	from	MeCS-PheCor.	d	Estimated	SE	from	MeCS	vs.	that	from	MeCS-PheCor.	Red	dash	lines	in	panel	b,	c,	and	d	represent	the	diagonal	lines	(y	=	x).			
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Supplementary	Figure	17	MeCS	results	from	simulations	under	the	alternative	hypothesis	that	the	eQTL	effects	are	non-zero	and	vary	across	tissues.	MeCS-PheCor	represents	a	MeCS	analysis	where	𝜃	is	estimated	from	individual-level	data.	a	Estimated	𝜃	from	summary-level	data	vs.	that	from	 individual-level	 data.	b	 Distribution	 of	 estimated	meta-analysis	 effect	 size	 from	MeCS.	 c	Estimated	meta-analysis	effect	size	from	MeCS	vs.	that	from	MeCS-PheCor.	d	Estimated	SE	from	MeCS	vs.	that	from	MeCS-PheCor.	Red	dash	lines	in	panel	a,	c,	and	d	represent	the	diagonal	lines	(y	=	x).			
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Supplementary	Figure	18	Estimates	of	eQTL	effects	and	SE	from	MeCS	vs.	those	from	univariate	analysis	 of	 mean	 expression	 level.	 In	 the	 analysis	 of	 mean	 expression	 level,	 we	 performed	 a	standard	GWAS	analysis	of	the	mean	gene	expression	level	of	two	tissues.	a	Meta-analysis	effect	size	from	MeCS	vs.	that	from	a	univariate	analysis	of	mean	expression	level.	b	Estimated	SE	from	MeCS	vs.	that	from	a	univariate	analysis	of	mean	expression	level.	Red	dash	lines	represent	the	diagonal	lines	(y	=	x).		
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Supplementary	Figure	19	Mean	𝜒3	across	all	eQTLs	under	different	levels	of	𝜃	(-0.70,	-0.35,	0,	0.35	and	0.70).	Each	column	is	a	box-plot	of	the	mean	𝜒3	values	from	1,000	simulation	replicates	under	different	levels	of	𝜃.	The	mean	value	of	each	column	is	labelled	in	red.	Tissue	1	and	Tissue	2:	 single-tissue	 analyses.	Mean	expression	 level:	 a	 univariate	 analysis	 of	 the	mean	expression	level	 of	 two	 tissues.	MeCS-PheCor:	MeCS	 analysis	with	𝜃 	estimated	 from	 individual-level	 data	(sample	overlap	=	1).			
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Supplementary	Figure	20	MeCS	analysis	of	the	10	GTEx	brain	regions.	a	Average	mean	𝜒3	for	all	eQTLs	across	all	probes	from	GTEx-brain,	10	brain	regions	individually,	and	GTEx-blood.	Note	that	 GTEx-brain	 represents	 a	MeCS	 analysis	 of	 10	 GTEx	 brain	 regions.	b	 Average	 number	 of	independent	significant	eQTLs	(from	PLINK	clumping	analysis)	per	gene	in	GTEx-brain,	10	brain	regions	individually,	and	GTEx-blood.	c	Box-plots	of	the	𝜒3	values	of	the	top	cis-eQTLs	in	GTEx-brain	and	10	GTEx	brain	regions	where	the	top	cis-eQTLs	were	ascertained	in	GTEx-blood	at	P	<	5´10-8.	The	mean	value	of	each	column	is	labelled	in	red.	d	Effective/actual	sample	size	for	GTEx-brain	and	10	brain	regions.		
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Supplementary	Figure	21	Estimated	variance	of	top	cis-eQTL	effects	across	genes	in	each	brain	region	in	GTEx.	The	top	cis-eQTLs	for	4,257	genes	(a	cis-eQTL	per	gene)	were	selected	at	P	<	5´10-8	 in	 GTEx-muscle.	 The	 variance	 of	 SNP	 effects	 was	 estimated	 by	 an	 approximate	 approach	var 𝑏 ≈ var 𝑏 − mean SE3 	where	var	and	mean	denote	the	sample	variance	and	mean	across	genes,	respectively.			
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Supplementary	Figure	22	Relationship	of	LD	r2	between	CMC	and	the	Health	and	Retirement	Study	(HRS).	HRS	is	used	as	the	reference	sample	in	HEIDI	test	for	LD	estimation.	Shown	are	the	LD	r2	between	1,500	pairs	of	adjacent	common	SNPs	on	chromosome	22	estimated	in	the	CMC	(n	=	621)	and	HRS	data	(n	=	7,703	European	Americans).	Both	x-	and	y-axes	are	limited	to	the	range	between	0.05	and	0.9	because	the	HEIDI	test	only	uses	LD	within	this	range.	There	are	observable	differences	in	LD	due	to	sampling	because	of	finite	sample	sizes.	These	differences	might	lead	to	an	increased	rejection	rate	for	HEIDI	but	not	affecting	the	false	discovery	rate	of	the	SMR	&	HEIDI	analysis.		
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Supplementary	Figure	23	Number	of	genes	associated	with	smoking	(a),	 IQ	(b),	SCZ	(c),	and	EduYears	(d)	in	eQTLGen	(blood)	and	Brain-eMeta	(brain).	The	genes	were	identified	by	the	SMR	analysis	using	GWAS	and	eQTL	summary	data.	
  
	
Supplementary	Figure	24	Number	of	DNAm	sites	associated	with	smoking	(a),	IQ	(b),	SCZ	(c),	and	EduYears	(d)	in	LBC+BSGS	(blood)	and	Jaffe	et	al.	(brain).	The	DNAm	sites	were	identified	by	the	SMR	analysis	using	GWAS	and	mQTL	summary	data.		
  
	
Supplementary	Figure	25	Number	of	genes	(a)	and	DNAm	sites	(b)	showed	pleiotropy	effects	(PSMR	<	1.8´10-6	and		PHEIDI	>	0.05)	with	4	brain-related	traits	by	an	integrative	analysis	of	GWAS	data	with	eQTL	(mQTL)	data	from	brain	and	blood	samples	using	the	SMR	&	HEIDI	approach.	The	four	brain-related	traits	are	smoking,	IQ,	SCZ	and	EduYears.	
  
	
Supplementary	Figure	26	Estimates	of	rb	between	two	tissues	for	cis-eQTLs	selected	at	different	thresholds	 from	 the	 reference	 tissue.	 Each	 analysis	 involves	 three	 tissues,	 one	 tissue	 as	 the	reference	for	selecting	the	top	associated	cis-eQTLs	and	the	other	two	tissues	for	the	estimation	of	rb.	GTEx-muscle	was	used	as	the	reference	tissue	to	select	the	top	associated	cis-eQTLs	at	5	different	 thresholds	 (i.e.	 5.0e-08,	 1.0e-06,	 1.0e-05,	 1.0e-04,	 and	 1.0e-03).	 GTEx-BR,	 GTEx-BR:	mean	estimate	of	rb	from	pairwise	brain	regions	in	GTEx.	GTEx-BR,	GTEx-blood:	mean	estimate	of	rb	between	blood	and	10	brain	regions	in	GTEx.	GTEx-BR,	CMC:	mean	estimate	of	rb	between	CMC	and	10	brain	regions	in	GTEx.	GTEx-blood,	CMC:	estimate	of	rb	between	GTEx-blood	and	CMC.		
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Supplementary	Figure	27	Estimates	of	rb	between	two	tissues	for	cis-eQTLs	selected	at	different	p-value	 thresholds	 in	 the	 reference	 tissue.	 The	 gene	 expression	 levels	 in	 three	 tissues	 were	simulated	 based	 on	 the	 UK10K	 data	 set	 with	 the	 SNPs	 in	 common	 with	 HapMap3	 (See	
Supplementary	Note	1	for	details).	In	each	simulation	replicate,	we	generated	1,000	probes.	The	true	 SNP	 effects	 were	 generated	 from	 a	 multivariate	 normal	 distribution	 with	 a	 correlation	parameter	 of	 0.7	 and	 the	 residues	 in	 gene	 expression	 levels	 were	 also	 simulated	 from	 a	multivariate	 normal	 distribution	 with	 a	 correlation	 parameter	 of	 0.20	 between	 tissues	(Supplementary	 Note	 1).	 The	 first	 tissue	 was	 used	 as	 the	 reference	 for	 selecting	 the	 top	associated	cis-eQTLs	at	a	p-value	threshold	and	the	other	two	tissues	were	used	to	estimate	rb	at	the	selected	cis-eQTLs.	Each	box	represents	 the	distribution	of	estimates	 from	100	simulation	replicates.	The	red	dash	 lines	 represent	 the	correlation	of	 the	 true	effects	generated	 from	the	simulation	for	the	corresponding	selected	probes.		
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Supplementary	Table	1	eQTL	summary	data	
Data	set	 Tissue	 n	 Data	type	 m	
No.	of	probes	
and/or	genes	GTEx	 Brain,	anterior	cingulate	cortex	BA24	 72	 RNA-Seq	 5,815,921	 23,509	GTEx	 Brain,	hippocampus	 81	 RNA-Seq	 6,110,317	 23,880	GTEx	 Brain,	hypothalamus	 81	 RNA-Seq	 6,097,172	 24,654	GTEx	 Brain,	putamen	basal	ganglia	 82	 RNA-Seq	 6,143,910	 23,362	GTEx	 Brain,	cerebellar	hemisphere	 89	 RNA-Seq	 6,241,253	 24,065	GTEx	 Brain,	frontal	cortex	BA9	 92	 RNA-Seq	 6,381,609	 24,120	GTEx	 Brain,	nucleus	accumbens	basal	ganglia	 93	 RNA-Seq	 6,406,794	 24,542	GTEx	 Brain,	cortex	 96	 RNA-Seq	 6,540,080	 24,366	GTEx	 Brain,	caudate	basal	ganglia	 100	 RNA-Seq	 6,573,031	 24,621	GTEx	 Brain,	cerebellum	 103	 RNA-Seq	 6,554,532	 24,762	GTEx	 Whole	blood	 338	 RNA-Seq	 9,206,530	 23,164	CMCa	 Dorsolateral	prefrontal	cortex	 467	 RNA-Seq	 1,102,001	 14,366	ROSMAP	 Brain,	cortex	 494	 RNA-Seq	 6,440,707	 12,979	Braineac	 10	CNS	tissues	 134	 Microarray	 6,187,834	 25,490	CAGE	 Peripheral	blood	 2,765	 Microarray	 7,763,174	 38,624	eQTLGen	 Peripheral	blood	 14,115	 Microarray	 10,209,777	 44,556	We	analyzed	eQTL	summary	data	spanning	brain	and	blood	from	6	datasets.	10	CNS	tissues	in	Braineac	are	 frontal	 cortex	 (FCTX),	hippocampus	 (HIPP),	medulla	 (specifically	 inferior	olivary	nucleus,	MEDU),	 occipital	 cortex	 (specifically	 primary	 visual	 cortex,	OCTX),	 putamen	 (PUTM),	substantia	 nigra	 (SNIG),	 thalamus	 (THAL),	 temporal	 cortex(TCTX),	 intralobular	 white	 matter	(WHMT),	 and	 cerebellar	 cortex	 (CRBL).	 For	 each	 tissue,	we	 listed	 the	 sample	 size,	 data	 type,	number	of	SNPs,	and	number	of	probes	and/or	genes.	aCMC,	only	SNP-gene	pairs	at	FDR	<	0.	20	were	available	in	the	public	domain.	For	the	other	data	sets,	we	had	the	full	eQTL	associations	in	the	cis-regions.	n:	sample	size;	m:	number	of	SNPs.	
  
Supplementary	Table	2	Number	of	matched	genes	out	of	4,257	selected	from	GTEx-muscle	between	different	data	sets	
Data	set	1	 Data	set	2	 No.	of	matched	genes	 Data	set	1	 Data	set	2	 No.	of	matched	genes	GTEx-brain1	 GTEx-brain2	 3,726	 GTEx-brain5	 GTEx-brain6	 3,827	GTEx-brain1	 GTEx-brain3	 3,652	 GTEx-brain5	 GTEx-brain7	 3,782	GTEx-brain1	 GTEx-brain4	 3,682	 GTEx-brain5	 GTEx-brain8	 3,794	GTEx-brain1	 GTEx-brain5	 3,735	 GTEx-brain5	 GTEx-brain9	 3,819	GTEx-brain1	 GTEx-brain6	 3,735	 GTEx-brain5	 GTEx-brain10	 3,771	GTEx-brain1	 GTEx-brain7	 3,717	 GTEx-brain5	 GTEx-blood	 3,575	GTEx-brain1	 GTEx-brain8	 3,716	 GTEx-brain5	 CMC	 1,436	GTEx-brain1	 GTEx-brain9	 3,720	 GTEx-brain5	 ROSMAP	 2,227		GTEx-brain1	 GTEx-brain10	 3,700	 GTEx-brain5	 Braineac	 2,191	GTEx-brain1	 GTEx-blood	 3,468	 GTEx-brain6	 GTEx-brain7	 3,775	GTEx-brain1	 CMC	 1,415	 GTEx-brain6	 GTEx-brain8	 3,788	GTEx-brain1	 ROSMAP	 2,186	 GTEx-brain6	 GTEx-brain9	 3,804	GTEx-brain1	 Braineac	 2,142	 GTEx-brain6	 GTEx-brain10	 3,765	GTEx-brain2	 GTEx-brain3	 3,738	 GTEx-brain6	 GTEx-blood	 3,546	GTEx-brain2	 GTEx-brain4	 3,776	 GTEx-brain6	 CMC	 1,434	GTEx-brain2	 GTEx-brain5	 3,827	 GTEx-brain6	 ROSMAP	 2,213		GTEx-brain2	 GTEx-brain6	 3,809	 GTEx-brain6	 Braineac	 2,176	GTEx-brain2	 GTEx-brain7	 3,787	 GTEx-brain7	 GTEx-brain8	 3,772	GTEx-brain2	 GTEx-brain8	 3,809	 GTEx-brain7	 GTEx-brain9	 3,776	GTEx-brain2	 GTEx-brain9	 3,841	 GTEx-brain7	 GTEx-brain10	 3,751	GTEx-brain2	 GTEx-brain10	 3,793	 GTEx-brain7	 GTEx-blood	 3,532	GTEx-brain2	 GTEx-blood	 3,581	 GTEx-brain7	 CMC	 1,430	GTEx-brain2	 CMC	 1,438	 GTEx-brain7	 ROSMAP	 2,208	GTEx-brain2	 ROSMAP	 2,227	 GTEx-brain7	 Braineac	 2,174	GTEx-brain2	 Braineac	 2,192	 GTEx-brain8	 GTEx-brain9	 3,799	GTEx-brain3	 GTEx-brain4	 3,776	 GTEx-brain8	 GTEx-brain10	 3,763	GTEx-brain3	 GTEx-brain5	 3,729	 GTEx-brain8	 GTEx-blood	 3,550	GTEx-brain3	 GTEx-brain6	 3,721	 GTEx-brain8	 CMC	 1,430	GTEx-brain3	 GTEx-brain7	 3,702	 GTEx-brain8	 ROSMAP	 2,205	GTEx-brain3	 GTEx-brain8	 3,717	 GTEx-brain8	 Braineac	 2,191	GTEx-brain3	 GTEx-brain9	 3,732	 GTEx-brain9	 GTEx-brain10	 3,782	GTEx-brain3	 GTEx-brain10	 3,692	 GTEx-brain9	 GTEx-blood	 3,562	GTEx-brain3	 GTEx-blood	 3,521	 GTEx-brain9	 CMC	 1,435	GTEx-brain3	 CMC	 1,425	 GTEx-brain9	 ROSMAP	 2,224	GTEx-brain3	 ROSMAP	 2,209	 GTEx-brain9	 Braineac	 2,186	GTEx-brain3	 Braineac	 2,156	 GTEx-brain10	 GTEx-blood	 3,522	GTEx-brain4	 GTEx-brain5	 3,781	 GTEx-brain10	 CMC	 1,425	GTEx-brain4	 GTEx-brain6	 3,750	 GTEx-brain10	 ROSMAP	 2,213	GTEx-brain4	 GTEx-brain7	 3,731	 GTEx-brain10	 Braineac	 2,174	GTEx-brain4	 GTEx-brain8	 3,744	 GTEx-blood	 CMC	 1,388	GTEx-brain4	 GTEx-brain9	 3,773	 GTEx-blood		 ROSMAP	 2,209	GTEx-brain4	 GTEx-brain10	 3,721	 GTEx-blood	 Braineac	 2,526	GTEx-brain4	 GTEx-blood	 3,569	 CMC	 ROSMAP	 1,043	GTEx-brain4	 CMC	 1,431	 CMC	 Braineac	 1,113	GTEx-brain4	 ROSMAP	 2,225	 ROSMAP	 Braineac	 1,354	GTEx-brain4	 Braineac	 2,177	 	 	 	We	selected	the	top	associated	cis-eQTLs	at	PeQTL	<	5´10-8	for	4,257	genes	in	GTEx-muscle	and	matched	those	selected	cis-eQTLs	and	genes	with	other	data	sets.	GTEx-brain1	–	GTEx-brain10	represent	10	brain	regions	 in	GTEx:	brain-anterior	cingulate	cortex	BA24,	brain-caudate	basal	ganglia,	brain-cerebellar	hemisphere,	brain-cerebellum,	brain-cortex,	brain-frontal	cortex	BA9,	brain-hippocampus,	 brain-hypothalamus,	 brain-nucleus	 accumbens	 basal	 ganglia,	 and	 brain-putamen	basal	ganglia.		
  
Supplementary	Table	3	mQTL	summary	data	
Data	set	 Tissue	 n	 m	 No.	of	probes	ROSMAPa	 Brain	cortical	 468	 5,211,394	 417,700	Hannon	et	al.b	 Fetal	brain	 166	 312,180	 26,840	Jaffe	et	al.c	 Frontal	cortex	 526	 1,544,693	 138,917	LBC	 peripheral	blood	 1,366	 9,183,310	 448,554	BSGS	 peripheral	blood	 614	 7,856,389	 417,059	LBC+BSGS	 peripheral	blood	 1,980	 7,664,968	 397,621	All	5	datasets	were	based	on	the	Illumina	HumanMethylation450K	array.	aROSMAP,	only	SNPs	within	5Kb	of	the	DNAm	probes	were	available;	bHannon	et	al.,	only	SNPs	with	PmQTL	<	1´10-10	were	available;	cJaffe	et	al.,	only	SNPs	with	FDR	<	0.1	(corresponding	to	PmQTL	<	8.6´10-4)	were	available;	n:	sample	size;	m	:	number	of	SNPs.							
  
Supplementary	Table	4	Number	of	matched	DNAm	probes	between	different	data	sets	
Data	set	1	 Data	set	2	 No.	of	matched	probes	BSGS	 LBC	 6,561	BSGS	 Jaffe	et	al.	 5,267	BSGS	 ROSMAP	 5,809	LBC	 Jaffe	et	al.	 5,416	LBC	 ROSMAP	 6,057	Jaffe	et	al.	 ROSMAP	 4,892	We	selected	the	top	associated	cis-mQTLs	at	PmQTL	<	1´10-10	for	26,840	DNAm	probes	in	the	data	from	Hannon	et	al.	and	matched	those	selected	cis-mQTLs	and	DNAm	probes	with	other	DNAm	data	sets.		
  
Supplementary	Table	5	P	value	of	fold	enrichment	for	tissue-specific	mQTLs	in	each	functional	category	
Category	 No.	of	mQTLs	
Fold	
enrichment	 SE	 t	 P	value	TssA	 140	 0.630	 0.122	 -3.033	 1.45´10-3	Prom	 655	 0.916	 0.059	 -1.424	 7.76´10-2	Tx	 546	 1.035	 0.081	 0.432	 3.33´10-1	TxWk	 331	 1.155	 0.124	 1.25	 1.06´10-1	TxEn	 254	 1.570	 0.181	 3.149	 9.17´10-4*	EnhA	 99	 1.675	 0.258	 2.616	 5.15´10-3	EnhW	 250	 1.416	 0.168	 2.476	 6.97´10-3	DNase	 75	 1.663	 0.405	 1.637	 5.29´10-2	ZNFRpts	 15	 0.876	 0.296	 -0.419	 3.41´10-1	Het	 57	 0.835	 0.162	 -1.018	 1.56´10-1	PromP	 40	 0.682	 0.211	 -1.507	 6.99´10-2	PromBiv	 168	 0.869	 0.151	 -0.867	 1.94´10-1	ReprPC	 353	 0.757	 0.074	 -3.284	 5.65´10-4	Quies	 2436	 0.924	 0.029	 -2.621	 4.42´10-3	
t	=	(fold	enrichment	-	1)/SE;	P	value	is	estimated	form	t-distribution.	The	red	asterisk	indicated	significant	enrichment	of	TD	after	the	correction	for	multiple	testing	(P	<	0.05/14).	
  
Supplementary	Table	6	Summary	data	of	GWAS	
Phenotype	 n	 ncase	 ncontrol	 No.	of	SNPs	SCZ	 150,064	 36,989	 113,075	 9,444,231	EduYears	 293,723	 /	 /	 8,146,841	smoking	 453,693	 208,988	 244,705	 7,288,503	IQ	 146,819	 /	 /	 7,288,503	We	included	4	brain-related	complex	traits	in	the	analysis.	GWAS	summary	statistics	for	SCZ	and	EduYears	were	from	the	latest	meta-analyses,	and	summary	data	for	smoking	and	IQ	were	from	GWAS	analysis	in	the	latest	release	of	the	UK	Biobank	(Methods).	n:	sample	size;	ncase:	number	of	cases;	ncontrol:	number	of	controls.		
  
Supplementary	Table	7	Replication	rate	of	top	eQTLs	selected	from	muscle	in	different	tissues	or	datasets	
Data	set	 Tissue	 n	 m	 5´10-8	 𝝅𝟏	GTEx	 Brain,	Anterior	cingulate	cortex	BA24	 72	 3,740	 0.115	 0.578	GTEx	 Brain,	hippocampus	 81	 3,810	 0.107	 0.599	GTEx	 Brain,	hypothalamus	 81	 3,860	 0.116	 0.599	GTEx	 Brain,	putamen	basal	ganglia	 82	 3,801	 0.131	 0.625	GTEx	 Brain,	cerebellar	hemisphere	 89	 3,759	 0.178	 0.650	GTEx	 Brain,	frontal	cortex	BA9	 92	 3,844	 0.148	 0.622	GTEx	 Brain,	nucleus	accumbens	basal	ganglia	 93	 3,871	 0.148	 0.626	GTEx	 Brain,	cortex	 96	 3,831	 0.171	 0.657	GTEx	 Brain,	caudate	basal	ganglia	 100	 3,884	 0.162	 0.649	GTEx	 Brain,	cerebellum	 103	 3,852	 0.210	 0.700	GTEx	 Whole	blood	 338	 3,821	 0.292	 0.715	CMC	 Dorsolateral	Prefrontal	Cortex	 467	 2,024	 0.528	 0.988	Braineac	 aveALLa	 134	 2,275	 0.056	 0.424	
aaveALL	represents	eQTLs	associated	with	average	gene	expression	across	10	brain	regions	in	Braineac.	n:	 sample	 size;	m:	number	of	 cis-eQTLs	 in	 common	with	 those	selected	 from	GTEx-muscle;	5´10-8:	replication	rate	at	P	<	5´10-8;	𝝅𝟏	(the	proportion	of	true	positive)	was	estimated	using	the	method	described	in	Storey	et	al.7.			
  
Supplementary	Note	1:	Simulation	studies	We	performed	a	series	of	simulations	based	on	a	whole-genome	sequencing	data	from	the	UK10K	project1.	 Details	 of	 the	 data	 and	 quantify	 control	 can	 be	 found	 elsewhere1.	 For	 simplicity,	we	limited	the	analysis	to	SNPs	on	chromosome	22	and	those	in	common	with	HapMap38,	and	further	excluded	SNPs	with	MAF	<	0.01	or	Hardy-Weinberg	Equilibrium	(HWE)	P	value	<	1×10-6.	There	were	16,805	SNPs	and	3,642	unrelated	individuals	included	in	the	simulation	studies.		
To	investigate	the	unbiasedness	of	rb	method	We	performed	 simulations	 to	 investigate	 the	 unbiasedness	 of	 the	 rb	method.	 To	 this	 end,	we	randomly	sampled	a	position	on	chromosome	22	and	defined	a	±	2Mb	window	centered	on	the	position	as	a	cis-region.	We	randomly	sampled	a	SNP	in	the	cis-region	as	the	causal	variant.	The	genetic	 effects	 of	 the	 causal	 variant	 in	 three	 tissues	 (one	 tissue	 was	 used	 for	 selecting	 top	associated	 cis-eQTLs,	 and	 the	 other	 two	 were	 used	 for	 estimating	 rb)	 were	 drawn	 from	 a	multivariate	 normal	 distribution,	𝐛~𝑀𝑉𝑁(𝟎, 1 𝜌F3 𝜌FG𝜌F3 1 𝜌3G𝜌FG 𝜌3G 1 ) ,	 with	𝜌	being	 the	 correlation	 of		SNP	effects	between	tissues.	Correlation	of	estimation	error	(𝑟')	may	occur	due	to	sample	overlap	and	phenotype	correlation,	and	therefore	we	generated	residual	error	(𝐞)	in	three	tissues	from	a	multivariate	normal	distribution,	𝐞~𝑀𝑉𝑁(𝟎, 𝐒),	where	𝐒	is	the	variance-covariance	matrix.	The	
ij-th	element	of	S	is	𝑆LM = 𝑟𝑒 var 𝑒L var 𝑒M 	,	where	var 𝑒L = 2𝑝(1 − 𝑝)𝑏L3( FO𝒊𝟐 − 1)	with	p	being	the	MAF,	bi	being	the	effect	size	of	the	causal	variant	in	tissue	i,	and	𝑞𝒊𝟐	being	the	proportion	of	variance	in	expression	level	of	a	gene	explained	by	the	causal	variant.	Five	levels	of	𝑟' 	(0.1,	0.3,	0.5,	0.7,	0.9)	were	considered.	Thus,	gene	expression	levels	in	the	three	tissues	for	each	of	3,642	individuals	in	our	sample	can	be	generated	from	a	linear	model	𝐘 = 𝐗𝐛 + 𝐞.	eQTL	effect	size	and	SE	in	cis-region	were	estimated	by	a	linear	regression	analysis	of	the	simulated	gene	expression	level	for	each	SNP	in	each	tissue.	We	repeated	this	process	for	2,000	times	to	mimic	the	data	for	2,000	genes.	We	then	repeated	the	whole	simulation	with	100	replications	for	each	level	of	𝑟' .				
To	investigate	the	unbiasedness	of	the	MeCS	method		To	 test	performance	of	MeCS,	we	also	 conducted	extensive	 simulations	based	on	UK10K	data	under	 the	null	and	alternative	hypotheses	pertaining	 to	eQTL	effect.	 	We	randomly	sampled	a	gene	position	and	a	causal	variant	in	cis-region	using	the	same	method	as	above	(Supplementary	
Note	 1).	We	 set	𝑏 = 1, 𝑞3 = 0.01,	 and	 simulated	𝑏L = 𝑏 + 𝑑L 	,	where	b	 is	 the	mean	 SNP	 effect	across	 all	 tissues,	 and	𝑑L 	is	 the	 deviation	 of	 SNP	 effect	 from	𝑏 	in	 tissue	 i,	𝑑L~𝑁(0,0.1) .	 For	simplicity,	we	assumed	that	there	are	only	2	tissues.	We	can	generate	the	expression	level	of	a	gene	in	the	2	tissues	by	a	simple	additive	model	𝐘 = 𝐗𝐛 + 𝐞	with	different	levels	of	𝜃,	where	𝐞	is	
  
generated	 from	 a	 multivariate	 normal	 distribution,		
𝐞~𝑀𝑉𝑁(𝟎, var 𝑒𝒊 𝜃 var 𝑒𝒊 var 𝑒𝒋𝜃 var 𝑒𝒊 var 𝑒𝒋 var 𝑒𝒋 ) 	.	 We	 then	 performed	 simple	 regression	analyses	to	estimate	eQTL	effect	sizes	and	SE	for	each	SNP	in	each	tissue.	Furthermore,	a	null	model	 (i.e.	𝑏 = 	𝑑L = 0)	was	used	 to	assess	 type	 I	 error.	Each	simulation	was	 replicated	1,000	times.	
	
Supplementary	Note	2:	Estimating	effective	sample	size	We	know	from	Yang	et	al.9	that	the	effective	sample	size	(neff)	can	be	calculated	as		𝑛[\\ = (𝜒3 − 1) 1 − 𝑞3𝑞3 	where	𝑞3	is	the	proportion	of	variance	in	gene	expression	explained	by	the	cis-eQTL.	We	selected	the	top	cis-eQTLs	from	GTEx-blood	at	P	<	5´10-8,	and	calculated	the	mean	𝜒3	value	of	these	SNPs	across	10	brain	regions	in	GTEx.	Assuming	that	𝑞3	is	similar	across	all	brain	regions,	𝑛[\\	of	the	meta-analyzed	GTEx-brain	data	can	be	estimated	from	the	following	equation	𝑛[\\]^_`abcdef𝑛bcdef_c[heif = (𝜒3 − 1)]^_`abcdef(𝜒3 − 1)bcdef_c[heif	where	𝑛jcdef	is	the	mean	sample	size	across	all	brain	regions,	and	(𝜒3 − 1)bcdef_c[heif	is	the	mean	of		mean	𝜒3	values	across	all	brain	regions.		
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